Latest Advocacy Group Content

Latest Content

How Has Cancer Affected Your Career?

October 19th 2020, 6:00pm

By Ryan McDonald


On social media, CURE® recently asked its readers to share how cancer has affected their careers.

Breast Cancer Action Month

October 19th 2020, 4:00pm

By Martha Carlson


How to turn breast cancer awareness into actions that can improve your life and those of people you love.

When Oncology Nurses Become Family

October 19th 2020, 1:00pm


Oncology nurses become family not just with one another, but their patients as well.

Sponsored by Bristol Myers Squibb: An Advanced Melanoma Diagnosis Didn’t Stop One College Student from Pursuing his Dreams of Medical School

October 19th 2020, 12:00pm


“Until Cancer, I Thought I Was Invincible”

Hope And The Patient With Cancer

October 18th 2020, 8:00pm

By Richard E. Farmer


Hope is a potent ally for the patient with cancer, and it is a response that helps inform a patient's journey with cancer.

When An Oncology Nurse Is Your Parental Guide

October 18th 2020, 1:00pm


On the cancer journey, oncology nurses are more than just a helping hand. They can be your second "mom" and guide you through the confusing parts.

A Week of Radiation Therapy Following Early-Stage Breast Cancer Surgery Appears as Safe and Effective as Longer Courses

October 17th 2020, 8:00pm

By Beth Fand Incollingo


Just one week of radiation therapy after surgery for early-stage breast cancer is as safe and effective as longer courses, researchers report.

Living As A 'Triple Threat' Breast Cancer Survivor

October 17th 2020, 6:00pm


Understanding cancer as a professional is one thing, but once you go through the journey it takes on a whole different understanding.

CURE®’s Annual Ovarian Cancer Heroes Program Goes Virtual Amid COVID-19 to Honor Three Women Who Have Dedicated Their Lives to Patients with Gynecologic Cancer

October 17th 2020, 1:00pm

By Conor Killmurray


An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

FDA Grants Regular Approval to Venclexta Combo for Untreated Acute Myeloid Leukemia

October 16th 2020, 6:20pm

By Kristie L. Kahl


After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.